Back
Zenas BioPharma Vs. Kairos Pharma Industry Stock Comparison
Sell
29
ZBIO
Zenas BioPharma
Last Price:
11.49
Seasonality Move:
1.54%
Sell
37
KAPA
Kairos Pharma
Last Price:
1.67
Seasonality Move:
--
Sell
29
Zenas BioPharma (ZBIO)
is a Sell
Is Zenas BioPharma a Buy, Sell or Hold?
- The current Zenas BioPharma [ZBIO] share price is $11.29. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Kairos Pharma (KAPA)
is a Sell
Is Kairos Pharma a Buy, Sell or Hold?
- The current Kairos Pharma [KAPA] share price is $1.70. The Score for KAPA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- KAPA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZBIO Stock Price Chart
What is Zenas BioPharma's stock price today?
-
The Zenas BioPharma share price today is $11.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZBIO is experiencing slight buying pressure.
KAPA Stock Price Chart
What is Kairos Pharma's stock price today?
-
The Kairos Pharma share price today is $1.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KAPA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.89 | Sell |
Relative Strength Index (14 RSI): | 27.2 | Sell |
Chaikin Money Flow: | 6963 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.98 - 23.04) | Sell |
Bollinger Bands (100): | (8.76 - 18.66) | Sell |
KAPA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 52.33 | Buy |
Chaikin Money Flow: | 75346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.28 - 1.76) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ZBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.95 | Sell |
20-day SMA: | 17.99 | Sell |
50-day SMA: | 17.4 | Sell |
200-day SMA: | 13.18 | Sell |
8-day EMA: | 13.73 | Sell |
20-day EMA: | 16.5 | Sell |
50-day EMA: | 16.68 | Sell |
200-day EMA: | 14.19 | Sell |
KAPA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.63 | Buy |
20-day SMA: | 1.54 | Buy |
50-day SMA: | 1.59 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 1.61 | Buy |
20-day EMA: | 1.59 | Buy |
50-day EMA: | 1.61 | Buy |
200-day EMA: | 0 | Buy |
Zenas BioPharma Earnings Growth & ZBIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $2.84 per share.
Kairos Pharma Earnings Growth & KAPA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.13 per share.
Zenas BioPharma Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kairos Pharma Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |